Living with neuroendocrine prostate cancer (NEPC) is challenging because the cancer is often aggressive. Researchers are looking closely at the tumor microenvironment, which is the complex neighborhood of cells, fluids, and chemicals surrounding the cancer. They want to understand how this environment helps the cancer grow and how it might be changed to help treatment work better.
Some evidence shows that many NEPC tumors have fewer immune cells, which are the body's natural defenders. Other studies in models suggest that factors like low oxygen and specific nutrients might help the cancer change its shape. One specific treatment targeting a protein called DLL3 has shown early activity in some patients who have specific markers for the disease.
It is important to note that much of this research is still in early stages. While some findings are promising, others, like how certain nutrients fuel the cancer or how dense tissue might block drugs, are not yet proven in humans. More research is needed to figure out exactly which parts of the tumor environment are the best targets for future treatments.
